We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-2.71%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$25.9B
AUM Growth
+$111M
(+0.43%)
Cap. Flow
+$958M
Cap. Flow
% of AUM
3.7%
Top 10 Holdings %
Top 10 Hldgs %
20.28%
Holding
1,881
New
76
Increased
812
Reduced
553
Closed
397
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$127M |
| 2 |
Colgate-Palmolive
CL
|
+$126M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$72.1M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$63.3M |
| 5 |
AT&T
T
|
+$61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$33.2M |
| 2 |
Carrier Global
CARR
|
+$29.6M |
| 3 |
RTX Corp
RTX
|
+$28.3M |
| 4 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$23.6M |
| 5 |
ABB
ABB Ltd
ABB
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.9% |
| 2 | Financials | 11.31% |
| 3 | Healthcare | 9.56% |
| 4 | Consumer Discretionary | 6.09% |
| 5 | Industrials | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cleveland-Cliffs
CLF
$6.99B
| $18.6M | 0.07% |
1,188,920
+1,173,543
| +7,632% | +$18.3M |
|
277
GSK
GSK
$106B
| $18.5M | 0.07% |
511,243
+80,919
| +19% | +$2.87M |
|
278
Vertex Pharmaceuticals
VRTX
$126B
| $18.4M | 0.07% |
52,890
+1,467
| +3% | +$513K |
|
279
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
| $18.4M | 0.07% |
414,816
+95,736
| +30% | +$4.49M |
|
280
Carter's
CRI
$1.47B
| $18.3M | 0.07% |
264,593
-27,089
| -9% | -$1.94M |
|
281
Digital Realty Trust
DLR
$71.7B
| $18.2M | 0.07% |
150,484
+26,290
| +21% | +$3.23M |
|
282
State Street Communication Services Select Sector SPDR ETF
XLC
$22.4B
| $18.2M | 0.07% |
277,086
+32,498
| +13% | +$2.17M |
|
283
Morgan Stanley
MS
$340B
| $18.1M | 0.07% |
221,755
-23,554
| -10% | -$2.05M |
|
284
ING
ING
$102B
| $18.1M | 0.07% |
1,373,612
-31,533
| -2% | -$444K |
|
285
Illumina
ILMN
$28.4B
| $18M | 0.07% |
134,737
+67,663
| +101% | +$11.1M |
|
286
Vanguard Industrials ETF
VIS
$8.39B
| $17.9M | 0.07% |
91,995
+443
| +0.5% | +$90.9K |
|
287
General Dynamics
GD
$106B
| $17.8M | 0.07% |
80,638
-25,243
| -24% | -$5.58M |
|
288
United Rentals
URI
$72.4B
| $17.6M | 0.07% |
39,687
-11,396
| -22% | -$5.22M |
|
|
XYZ
289
Block Inc
XYZ
$47.5B
| $17.5M | 0.07% |
395,851
+114,916
| +41% | +$7.12M |
|
290
iShares MSCI Emerging Markets ETF
EEM
$29.5B
| $17.5M | 0.07% |
461,527
+12,498
| +3% | +$495K |
|
291
Moderna
MRNA
$23.6B
| $17.5M | 0.07% |
169,544
+10,895
| +7% | +$1.22M |
|
292
ServiceNow
NOW
$129B
| $17.1M | 0.07% |
153,060
-3,490
| -2% | -$398K |
|
293
WisdomTree US MidCap Dividend Fund
DON
$4.09B
| $17.1M | 0.07% |
417,611
+6,573
| +2% | +$280K |
|
294
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
| $17M | 0.07% |
235,509
+6,851
| +3% | +$517K |
|
|
ANSS
295
DELISTED
Ansys
ANSS
| $16.9M | 0.07% |
56,653
+15,156
| +37% | +$4.8M |
|
296
BHP
BHP
$230B
| $16.9M | 0.07% |
296,308
+26,360
| +10% | +$1.54M |
|
297
Invesco Preferred ETF
PGX
$3.79B
| $16.8M | 0.07% |
1,538,789
-60,422
| -4% | -$676K |
|
298
SLM Corp
SLM
$5.15B
| $16.8M | 0.06% |
1,234,669
-171,936
| -12% | -$2.59M |
|
299
Diageo
DEO
$53.6B
| $16.8M | 0.06% |
112,643
+364
| +0.3% | +$60.9K |
|
300
Coinbase
COIN
$40.5B
| $16.8M | 0.06% |
223,881
+9,246
| +4% | +$779K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Rockefeller Capital Management held 1,881 positions worth $25.9B, up 0.43% from $25.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $958M of net new capital in Q3 2023, opening 76 new positions and adding to 812 existing holdings. Its largest new stake was Noble Corp: 279,429 shares worth $14.2M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $33.2M trimmed.
- Rockefeller Capital Management's largest Q3 2023 buy was Noble Corp: 279,429 shares worth $14.2M.
- Rockefeller Capital Management added most to Oracle in Q3 2023, an estimated $127M increase.
- Rockefeller Capital Management's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $33.2M.
- Rockefeller Capital Management fully exited ABB Ltd in Q3 2023, selling an estimated $23.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $25.9B portfolio in Q3 2023.
- Rockefeller Capital Management opened 76 new positions and closed 397 in Q3 2023.
- Rockefeller Capital Management's portfolio value rose 0.43% quarter-over-quarter to $25.9B.
Based on Rockefeller Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.